A Phase I Open-Label Study to Identify a Dosing Regimen of the Pan-AKT Inhibitor AZD5363 for Evaluation in Solid Tumors and in PIK3CA -Mutated Breast and Gynecologic Cancers

Banerji, Udai ; Dean, Emma J ; Pérez-Fidalgo, J Alejandro ; Batist, Gerald ; Bedard, Philippe L ; You, Benoit ; Westin, Shannon N ; Kabos, Peter ; Garrett, Michelle D ; Tall, Mathew ; Ambrose, Helen ; Barrett, J Carl ; Carr, T Hedley ; Cheung, S Y Amy ; Corcoran, Claire ; Cullberg, Marie ; Davies, Barry R ; de Bruin, Elza C ; Elvin, Paul ; Foxley, Andrew ; Lawrence, Peter ; Lindemann, Justin P O ; Maudsley, Rhiannon ; Pass, Martin ; Rowlands, Vicky ; Rugman, Paul ; Schiavon, Gaia ; Yates, James ; Schellens, Jan H M

Clinical cancer research, 2018-05, Vol.24 (9), p.2050-2059 [Periódico revisado por pares]

United States: American Association for Cancer Research Inc

Texto completo disponível